[HTML][HTML] The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China
The city of Wuhan in China is the focus of global attention due to an outbreak of a febrile
respiratory illness due to a coronavirus 2019-nCoV. In December 2019, there was an outbreak …
respiratory illness due to a coronavirus 2019-nCoV. In December 2019, there was an outbreak …
[HTML][HTML] Remdesivir for 5 or 10 days in patients with severe Covid-19
Background Remdesivir is an RNA polymerase inhibitor with potent antiviral activity in vitro
and efficacy in animal models of coronavirus disease 2019 (Covid-19). Methods We …
and efficacy in animal models of coronavirus disease 2019 (Covid-19). Methods We …
Middle East respiratory syndrome
… Prof David S Hui, FRCP David S Hui … Protease cleavage of the S protein is then required
for virus–cell fusion and release of genomic RNA into the cytoplasm. Viral RNA transcription …
for virus–cell fusion and release of genomic RNA into the cytoplasm. Viral RNA transcription …
Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients
BACKGROUND:: The effect of corticosteroid treatment on the viral load of Severe Acute
Respiratory Syndrome (SARS) patients is unknown. OBJECTIVE:: To compare the plasma SARS-…
Respiratory Syndrome (SARS) patients is unknown. OBJECTIVE:: To compare the plasma SARS-…
Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis
Objectives To evaluate the haematological findings of patients with severe acute respiratory
syndrome (SARS). Design Analysis of the demographic, clinical, and laboratory …
syndrome (SARS). Design Analysis of the demographic, clinical, and laboratory …
[HTML][HTML] Reducing mortality from 2019-nCoV: host-directed therapies should be an option
The number of confirmed cases of the 2019 novel coronavirus (2019-nCoV) reported to
WHO continues to rise worldwide. 1 As with two other WHO Blueprint priority coronaviruses, …
WHO continues to rise worldwide. 1 As with two other WHO Blueprint priority coronaviruses, …
The long‐term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status
Background and objective: Severe acute respiratory syndrome (SARS) emerged in 2003
and its long‐term sequelae remain largely unclear. This study examined the long‐term …
and its long‐term sequelae remain largely unclear. This study examined the long‐term …
Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia
Retrospective studies have suggested that combination antibiotic therapy for severe
bacteremic pneumococcal pneumonia may reduce mortality. We assessed this issue in a …
bacteremic pneumococcal pneumonia may reduce mortality. We assessed this issue in a …
[HTML][HTML] Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission
Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonosis that causes
death in 35·7% of cases. As of Feb 28, 2018, 2182 cases of MERS-CoV infection (with 779 …
death in 35·7% of cases. As of Feb 28, 2018, 2182 cases of MERS-CoV infection (with 779 …
Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks
Background High-flow nasal cannula (HFNC) is an emerging therapy for respiratory failure
but the extent of exhaled air dispersion during treatment is unknown. We examined exhaled …
but the extent of exhaled air dispersion during treatment is unknown. We examined exhaled …